JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q1 2020 Results - Earnings Call Transcript
Jazz Pharmaceuticals plc (JAZZ)
Q1 2020 Earnings Conference Call
May 05, 2020 04:30 PM ET
Company Participants
Kathy Littrell - Head of Investor Relations
Bruce Cozadd - CEO
Dan Swisher - President
Renee Gala - CFO
Rob Iannone - Executive Vice President, R&D
Mike Miller - Executive Vice President, U.S. Commercial
Phil Jockelson - Sweep and Neuroscience Therapeutic Head
Ann Borgman - Hematology and Oncology Therapeutic Head
Jed Black - Senior Vice President, Sleep and Neuroscience
Sean Mendes - Senior Vice President, Strategy and Finance
Conference Call Participants
Brandon Folkes - Cantor Fitzgerald
Gary Nachman